This study was undertaken to investigate the association between placenta previa and Down syndrome screening analytesΓalpha-fetoprotein (AFP) and hCGΓduring the second trimester. Measurements of maternal serum AFP and hCG concentrations were retrospectively analysed in relation to placenta previa in
Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy
β Scribed by Bartels, Iris ;Thiele, Marion ;Bogart, Mark H.
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 384 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We determined the aneuploidy detection rate achievable by early pregnancy screening with pregnancy associated plasma protein (PAPP)-A, free human chorionic gonadotrophin (hCG) and ultrasound nuchal translucency (NT) measurement. Women having prenatal diagnosis were scanned, and a blood sample was ta
Stored maternal urine samples were used to determine the distribution of hyperglycosylated human chorionic gonadotrophin (H-hCG) levels in pregnancies with Down syndrome. A total of 349 samples from singleton pregnancies, including 45 with Down syndrome, were tested at 10-19 weeks' gestation. Urinar
To assess the influence of in vitro fertilization (IVF) on maternal serum human chorionic gonadotrophin (hCG) and alpha-fetoprotein (AFP), the maternal serum hCG and AFP values were studied in 67 IVF pregnancies and compared with the results of a control group of 4732 spontaneously conceiving patien